2,658
Views
4
CrossRef citations to date
0
Altmetric
Research Article

High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Guillermo J. Ruiz-Argüelles, Adriana Seber & Guillermo J. Ruiz-Delgado. (2022) Conducting hematopoietic stem cell transplantation in low and middle income countries. Hematology 27:1, pages 809-812.
Read now

Articles from other publishers (3)

Sarmiento M, Rojas P, Gutierrez C, Quezada J, Jara V, Campbell J, Garcia MJ, Sandoval V, Vergara M, Triantafilo N & Ocqueteau M. (2023) Autologous stem cell transplant in lymphoma using a noncryopreserved platform: an adapted sequential conditioning maintaining dose intensity does not affect transplantation outcomes.. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Al-Anazi Khalid Ahmed, A Alshami, E Mutahar, O Abduljalil, S Kanfer, P Kaloyannidis, J Bacal, A Estanislao, I Apostolidis, N Almokhtar, M Darweesh, M Abdulbaqi, W Alenazi, Z Alshammasi, O Albanyan, A Ayyad, Z Alsomali, M Albatran, H Raslan, A Albahrani, A Alsaber, N AlMulhem, W Dridi, R Alrabeh, F Abu Rahma, F Nightingale, P Ahadai & H Alhashmi. (2023) Outcome of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma and Relapsed and Refractory Hodgkin Lymphoma. The Experience of King Fahad Specialist Hospital in Dammam, Saudi Arabia. Journal of Stem Cell Therapy and Transplantation 7:1, pages 003-015.
Crossref
Ga-Young Song, Sung-Hoon Jung, Jin Seok Kim, Hyeon Seok Eom, Joon Ho Moon, Ho-Young Yhim, Kihyun Kim, Chang-Ki Min & Je-Jung Lee. (2022) Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study). Frontiers in Oncology 12.
Crossref